Vitiligo treatment algorithm
- Authors: Lomonosov K.M.1, Gereykhanova L.G1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 19, No 3 (2016)
- Pages: 167-169
- Section: Articles
- URL: https://bakhtiniada.ru/1560-9588/article/view/37114
- DOI: https://doi.org/10.18821/1560-9588-2016-19-3-167-169
- ID: 37114
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Konstantin M. Lomonosov
I.M. Sechenov First Moscow State Medical University
Email: lamdinic@yandex.ru
MD, PhD, DSc, prof. Department of skin venereal diseases of medical faculty I.M. Sechenov First Moscow State Medical University Moscow, 119991, Russian Federation
L. G Gereykhanova
I.M. Sechenov First Moscow State Medical UniversityКафедра кожных и венерических болезней им. В.А. Рахманова лечебного факультета Moscow, 119991, Russian Federation
References
- Picardo M., Dell’Anna M.L., Ezzedine K., Hamzavi I., Harris J.E., Parsad D., Taieb A. Vitiligo. Nat. Rev. Dis. Primers. 2015; 1: 15046. doi: 10.1038/nrdp.2015.46. http://go.nature.com/vIhFSC.
- Ezzedine K., Lim H.W., Suzuki T., Katayama I., Hamzavi I., Lan C.C., et al.; Vitiligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment. Cell Melanoma Res. 2012; 25(3): E1-13. doi: 10.1111/j.1755-148X.2012.00997.x.
- Бабешко О.А. Патогенетическое обоснование комплексной дифференцированной терапии витилиго. Available at: http://www.dslib.net/bolezni-kozhi/patogeneticheskoe-obosnovaniekompleksnoj-differencirovannoj-terapii-vitiligo.html (последний доступ 10.03.2016).
- Герейханова Л.Г., Ломоносов К.М, Башлакова К.А. Окислительный стресс в патогенезе витилиго и методы его коррекции. Российский журнал кожных и венерических болезней. 2016; 19(1): 45-8.
- Hann S.K., Gauthier Y., Benzekri L. Generalized vitiligo. In: Picardo M., Taieb A., eds. Vitiligo. Springer; 2010. Ch.1.3.2: 41-9.
- Sapam R., Agrawal S., Dhali T.K. Systemic PUVA vs narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int. J. Dermatol. 2012; 51(9): 1107-15. doi: 10.1111/j.1365-4632.2011.05454.x.
- Lim H.W., Grimes P.E., Agbai O., Hamzavi I., Henderson M., Haddican M., et al. Afamelanotide and narrowband UVB phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015; 151(1): 42-50. doi: 10.1001/jamadermatol.2014.1875.
- Dong D., Jianq M., Xu X., Guan M., Wu J., Chen Q., Xiang L. The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro. J. Dermatol. Sci. 2012; 66(1): 20-8. doi: 10.1016/j.jdermsci.2012.01.012.
- Gawkrodger D.J., Ormerod A.D., Shaw L., Mauri-Sole I., Whitton M.E., Watts M.J., et al.; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists; Clinical Standards Department, Royal College of Physicians of London; Cochrane Skin Group; Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br. J. Dermatol. 2008; 159(5): 1051-76. doi: 10.1111/j.1365-2133.2008.08881.x.
Supplementary files
